There are approximately 10-15 million people worldwide who are simultaneously infected with Hepatitis B and D (HBV and HDV). Patients who have a chronic hepatitis D virus infection often show a severe course to the development of (cirrhosis) or liver cancer. There are currently few therapeutic options for these patients.
It is of great interest to characterize exactly how the immunological reaction progresses in the …
read on »